SIGN IN
Quality Control Co-op jobs in United States
cer-icon
Apply on Employer Site
company-logo

Keros Therapeutics · 18 hours ago

Quality Control Co-op

Keros is a company focused on delivering clinical benefits through innovative product candidates targeting TGF-β signaling. The Quality Control Co-op role involves supporting quality control stability programs, including the development and documentation of stability studies and data management.
BiotechnologyHealthcarePharmaceuticalHealth CareTherapeutics
check
H1B Sponsor Likelynote

Responsibilities

Participate in the design of stability studies
Participate in the shipment of stability samples as needed
Track the progress of timely Drug Substance, Drug Product, Placebo stability testing
Input of stability data into stability database
Upload of a backlog of stability data into a document management system
Participate in the establishment of product shelf life

Qualification

Protein biochemistryBiology lab techniquesStatistical analysisScientific presentationHighly organizedTechnical writingMicrosoft SuiteJMP software

Required

Familiar with protein biochemistry
Familiar with general biology lab techniques
Familiar with statistical analysis
Technical and scientific writing and presentation skills
Highly organized
Currently enrolled in a biology, chemistry, biochemistry or related program

Preferred

Experience with Microsoft suite of applications
Experience with JMP statistical software

Company

Keros Therapeutics

twittertwitter
company-logo
Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.

H1B Sponsorship

Keros Therapeutics has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2024 (2)
2023 (1)
2022 (3)
2021 (1)

Funding

Current Stage
Public Company
Total Funding
$379.5M
Key Investors
Cowen Healthcare Investments,Foresite Capital,OrbiMed,VenrockPontifax
2024-01-03Post Ipo Equity· $140M
2020-11-13Post Ipo Equity· $149.5M
2020-04-07IPO

Leadership Team

leader-logo
Lorena Lerner
Chief Scientific Officer
linkedin
Company data provided by crunchbase